How do you avoid and treat steroid side effects?

2008 ◽  
Vol 14 ◽  
pp. S214-S215 ◽  
Author(s):  
Simon Travis
JAMA ◽  
1982 ◽  
Vol 247 (19) ◽  
pp. 2657 ◽  
Author(s):  
William A. Check

2001 ◽  
Vol 59 (2B) ◽  
pp. 347-352 ◽  
Author(s):  
Rosana Herminia Scola ◽  
Lineu Cesar Werneck ◽  
Daniel Monte Serrat Prevedello ◽  
Priscila Greboge ◽  
Fábio Massaiti Iwamoto

We report on the clinical course and histopathologic muscle alterations of five patients diagnosed with neurosarcoidosis, who underwent biopsy due to their muscle manifestations. The five patients were females and only one was less than 40 years of age. Proximal muscle weakness was presented by all and only two patients complained of myalgia. Only normal values of serum muscle enzymes were detected. Electromyography revealed diverse findings such as normal, myopathic and neuropathic patterns. Granuloma was not present in one muscle biopsy. Two patients thoroughly recovered by taking only prednisone and one patient required a methotrexate addition for 3 months before becoming asymptomatic. The other two patients received azathioprine, one due to steroid side effects but without a satisfactory evolution, and the other to strengthen the prednisone régime, with excellent results.


1999 ◽  
Vol 31 (1-2) ◽  
pp. 301-302 ◽  
Author(s):  
D.L Veenstra ◽  
J.H Best ◽  
J Hornberger ◽  
S.D Sullivan ◽  
D.E Hricik

2021 ◽  
pp. 49-51
Author(s):  
Paramasivam Preethi ◽  
R.R. Mahendra Raj ◽  
Thalaimalai Saravanan ◽  
K.R. Shakila

Corticosteroid remains mainstay of treatment for immune mediated mucocutaneous disorders. The very usefulness of the drug, which has become a double-edged sword, when used for long time. The administration of immunomodulators decrease the dose of steroids, reduces the steroid side effects and improves rejuvenation time. In addition to immunomodulatory drugs there are some drugs that are used to spare corticosteroids in the treatment of immune mediated mucocutaneous diseases. This review attempts to elicit the use of steroid sparing drugs in immune mediated diseases.


1998 ◽  
Vol 30 (4) ◽  
pp. 1303-1304 ◽  
Author(s):  
E Bertoni ◽  
M Zanazzi ◽  
A Rosati ◽  
L Di Maria ◽  
L Moscarelli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document